Summary of Purpose
To test the hypothesis that higher doses of tirilazad mesylate are required to prevent vasospasm and improve outcome in women with subarachnoid hemorrhage (SAH).Read More →
The following dates are available for this trial. Trial information last updated on 13 August 2008.
|Start Date||First Received||1st Completion||Completion||Verification||Results|
- Pharamacia-Upjohn, Inc., Kalamazoo, MI
Parallel, multi-center, randomized, stratified trial of 819 patients at 56 neurological centers in Europe, Australia, New Zealand and South Africa.